| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 11/25/2008 | US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody |
| 11/25/2008 | US7455837 Compositions and methods for the diagnosis and treatment of sepsis |
| 11/25/2008 | US7455836 Administering an agent which antagonizes the effects of a colony stimulating factor on these monocyte/macrophage cells to lower levels or reduce their activity; treating inflammation |
| 11/25/2008 | US7455834 Methods and compositions for modulating and detecting WISP activity |
| 11/25/2008 | US7455833 Antitumor, anticancer agents; complexing phosphatide with antibody, duramycin; prevent reproduction of virus |
| 11/25/2008 | CA2323687C Mutant recombinant allergens |
| 11/25/2008 | CA2264776C Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 11/20/2008 | WO2008141321A1 Methods and device to neutralize soluble toxic agents in the brain |
| 11/20/2008 | WO2008141278A1 Method for preparing antibody conjugates |
| 11/20/2008 | WO2008141044A2 Cysteine engineered anti-muc16 antibodies and antibody drug conjugates |
| 11/20/2008 | WO2008140826A1 Compositions and methods for diagnosing and treating cancer |
| 11/20/2008 | WO2008140812A2 Compositions and methods comprising klk3, psca, or folh1 antigen |
| 11/20/2008 | WO2008140653A2 Humaneered anti-factor b antibody |
| 11/20/2008 | WO2008140632A2 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 11/20/2008 | WO2008140622A2 Modified polymerases and attenuated viruses and methods of use thereof |
| 11/20/2008 | WO2008140610A2 Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast |
| 11/20/2008 | WO2008140603A2 METHODS FOR THE TREATMENT OF DISEASE USING IMMUNOGLOBULINS HAVING FC REGIONS WITH ALTERED AFFINITIES FOR FCγR ACTIVATING AND FCγR INHIBITING |
| 11/20/2008 | WO2008140602A2 USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND α4β7 INTEGRIN |
| 11/20/2008 | WO2008140598A2 Novel immunotherapeutic mycobacteria, pharmaceutic formulations and uses thereof |
| 11/20/2008 | WO2008140586A2 Modulation of rhamm (cd168) for selective adipose tissue development |
| 11/20/2008 | WO2008140579A2 Induction of broadly reactive neutralizing antibodies by focusing the immune response on v3 epitopes of the hiv-1 gp120 envelope |
| 11/20/2008 | WO2008140577A2 Cd44 pathway antagonists for treatment of adenoviral infection |
| 11/20/2008 | WO2008140542A2 Methods to decrease the risk of metabolic syndrome post immunization |
| 11/20/2008 | WO2008140493A2 Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof |
| 11/20/2008 | WO2008140478A2 Compositions and methods for immunodominant antigens |
| 11/20/2008 | WO2008140474A1 Recombinant adenovirus vaccines |
| 11/20/2008 | WO2008140463A2 Biomarker panels for assessing radiation injury and exposure |
| 11/20/2008 | WO2008140414A1 Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (pcv2) infection |
| 11/20/2008 | WO2008140353A1 AGENT EXHIBITING PROPERTIES TO FORM THE CELLULAR IMMUNITY AGAINST MYCOBACTERIUM TUBERCULOSIS H37 Rv, METHOD FOR THE PRODUCTION THEREOF (VARIANTS), A RECOMBINANT STRAIN AND AN AGENT FOR TUBERCULOSIS DIAGNOSIS |
| 11/20/2008 | WO2008140316A1 Means and methods for enhancing differentiation of haematopoietic progenitor cells |
| 11/20/2008 | WO2008140296A1 Means and methods for enhancing differentiation of haematopoietic progenitor cells |
| 11/20/2008 | WO2008139202A1 Neutralizing monoclonal antibody against human dll4 |
| 11/20/2008 | WO2008138999A1 Chlamydia vaccine |
| 11/20/2008 | WO2008138590A1 Composition containing hcmv particles |
| 11/20/2008 | WO2008138533A1 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines |
| 11/20/2008 | WO2008138229A1 Recombinant protein expression system with enhanced yield and immunogenicity |
| 11/20/2008 | WO2008138139A1 Carbohydrate-containing pan cancer marker |
| 11/20/2008 | WO2008138120A1 Avian influenza h5n1 hemagglutilin pseudotyped lentiviral vector system for rapid identification of antivirals and neutralizing polypeptides |
| 11/20/2008 | WO2008138072A1 Treatment and prevention of influenza |
| 11/20/2008 | WO2008118752A3 Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides |
| 11/20/2008 | WO2008118356A3 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
| 11/20/2008 | WO2008115631A9 Plant-produced compositions for treating papillomavirus infection and related methods |
| 11/20/2008 | WO2008115470A3 Hox-gene expression as a biomarker for igf-1r therapeutics |
| 11/20/2008 | WO2008114011A3 Fc polypeptide variants obtained by ribosome display methodology |
| 11/20/2008 | WO2008112003A3 Targeted binding agents directed to pdgfr-alpha and uses thereof |
| 11/20/2008 | WO2008109667A3 Bacterial extract for digestive or urinary tract disorders and process for its preparation |
| 11/20/2008 | WO2008108910A3 Negative genetic regulation of cancer cell renewal in synergy with notch- or numb-specific immunotherapy |
| 11/20/2008 | WO2008100816A3 Antibody libray display by yeast cell plasma membrane |
| 11/20/2008 | WO2008100562A3 Indoleamine 2,3-dioxygenase, pd-1/pd-l pathways, and ctla4 pathways in the activation of regulatory t cells |
| 11/20/2008 | WO2008097863A3 Methods for producing yeast-based vaccines |
| 11/20/2008 | WO2008093280A3 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen |
| 11/20/2008 | WO2008092084A3 Injectable non-aqueous suspension with high concentration of therapeutic agent |
| 11/20/2008 | WO2008074839A3 Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders |
| 11/20/2008 | WO2008073333A3 Vaccine for periodontitis and methods of use |
| 11/20/2008 | WO2008070569A3 Human antibodies that bind cd22 and uses thereof |
| 11/20/2008 | WO2008070344A3 Compositions and methods for binding sphingosine-1-phosphate |
| 11/20/2008 | WO2008070137A3 Interferon alpha-induced pharmacodynamic markers |
| 11/20/2008 | WO2008070090A3 Compositions and methods for diagnosing and treating cancer |
| 11/20/2008 | WO2008067040A3 Method of detecting ocular diseases and pathologic conditions and treatment of same |
| 11/20/2008 | WO2008064181A3 Prime boost canine leishmania vaccine |
| 11/20/2008 | WO2008058706A3 Enterococcus faecalis and/or enterococcus faecium antigen |
| 11/20/2008 | WO2008057171A3 4-1 bb ligand in inflammatory diseases |
| 11/20/2008 | WO2008016984A3 Polysaccharide vaccine and uses thereof |
| 11/20/2008 | WO2008006118A3 Novel regimens for treating diseases and disorders |
| 11/20/2008 | WO2008006117A3 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures |
| 11/20/2008 | WO2008005859A3 Dendritic cells generated using gm-csf and interferon alpha and loaded with heat-treated and killed cancer cells |
| 11/20/2008 | WO2007149491A3 Soluble stabilized trimeric hiv env proteins and uses thereof |
| 11/20/2008 | WO2007130455A3 Compositions and methods for treatment of non-hodgkins lymphoma |
| 11/20/2008 | WO2007127204A3 Methods and compositions relating to immunostimulation |
| 11/20/2008 | WO2007124354A3 Use of tight junction agonists to facilitate pulmonary delivery of therapeutic agents |
| 11/20/2008 | WO2007123661A3 Treatment of tumors expressing mutant egf receptors |
| 11/20/2008 | WO2007117490A3 Antibody purification |
| 11/20/2008 | WO2007098267A3 Pseudoinfectious flavivirus and uses thereof |
| 11/20/2008 | WO2007095643A3 Methods for improving immune function and methods for prevention or treatment of disease in a mammalian subject |
| 11/20/2008 | WO2007094999A3 Ungual antifungal compositions |
| 11/20/2008 | WO2007058968A3 Gene expression profiles and methods of use |
| 11/20/2008 | WO2006130429A3 Treatment of cancer |
| 11/20/2008 | WO2006076736A3 Methods for modulating angiogenesis, lymphangiogenesis, and apoptosis with apelin compositions |
| 11/20/2008 | WO2005089527A3 Lytic enzymes and spore surface antigen for detection and treatment of bacillus anthracis bacteria and spores |
| 11/20/2008 | WO2004030615A8 Compositions and methods for the diagnosis and treatment of tumor |
| 11/20/2008 | WO2003061577A8 Polyalkylene glycol with moiety for conjugating biologically active compound |
| 11/20/2008 | US20080289055 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 11/20/2008 | US20080288627 Storage network and method for storage network device mapping |
| 11/20/2008 | US20080287664 Hsp60 from arthrobacter |
| 11/20/2008 | US20080287657 Modified immunoglobulin receptor for use as enhanced indicator tool immunological detection; protein detection |
| 11/20/2008 | US20080287366 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 11/20/2008 | US20080287348 Soluble Hybrid Prion Proteins And Their Use In The Diagnosis, Prevention And Treatment Of Transmissible Spongiform Encephalopathies |
| 11/20/2008 | US20080286868 Metal binding compounds and their use in cell culture medium compositions |
| 11/20/2008 | US20080286861 Compositions and Methods for the Treatment of Immune Related Diseases |
| 11/20/2008 | US20080286848 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS |
| 11/20/2008 | US20080286817 Novel allergens and treatment |
| 11/20/2008 | US20080286804 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy |
| 11/20/2008 | US20080286781 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 11/20/2008 | US20080286756 Compositions and methods for diagnosing and treating severe acute respiratory syndrome (sars) |
| 11/20/2008 | US20080286389 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 11/20/2008 | US20080286375 capable of releasing a protein drug continuously over a long period of time without initial burst release; dissolving a protein drug in H2o to obtain a water phase; dissolving sucrose acetate isobutyrate and a biodegradable polymer in an organic solvent to obtain an oil phase, emulsifying |
| 11/20/2008 | US20080286370 Nanoscale Particles Used as Contrasting Agents in Magnetic Resonance Imaging |
| 11/20/2008 | US20080286369 water soluble particles include e.g. those with a crystalline core of D,L-valine and a coating of insulin or a crystalline core of L-glycine and a coating of antitrypsin; for pulmonary delivery; coprecipitation |
| 11/20/2008 | US20080286361 deliverying a therapeutic agent (DNA, CFTR genes, peptide, antibody etc. ) contained in targeting particles (e.g. magnetite) to a cell using an electromagnet to apply a magnetic force so as to tend to move particles towards magnet and at the same time moving the magnet |
| 11/20/2008 | US20080286353 Cationic liposomes containing immune response generating moieties |